Pharmaceuticals, Biotechnology and Life Sciences
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-endCAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) —…
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…
– Peer-reviewed publication highlights 22 new oncogenic HER2 driver mutations identified and experimentally validated with MAP discovery engine – CAMBRIDGE,…
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting Shareholders Approved All…
BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON,…
– Dr. O’Donnell-Tormey is a cancer immunology key opinion leader with more than 30 years leading the Cancer Research Institute’s…
CHARLOTTESVILLE, Va. and CARMEL, Ind., May 11, 2022 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical…
New facility will also serve as regional headquarters for Singleron in Asia Proteona opens new laboratory in Singapore New laboratory…
NEW HAVEN, CONN., U.S.A., May 10, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC.. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”) a…
May 10, 2022 Breda, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving…